Idecabtagene vicleucel in relapsed and refractory multiple myeloma

Original Article from The New England Journal of Medicine — Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Saved in:
Bibliographic Details
Main Authors: Munshi, Nikhil C. (Author) , Larry D. Anderson, Jr (Author) , Shah, Nina (Author) , Madduri, Deepu (Author) , Berdeja, Jesús (Author) , Lonial, Sagar (Author) , Raje, Noopur (Author) , Lin, Yi (Author) , Siegel, David (Author) , Oriol, Albert (Author) , Moreau, Philippe (Author) , Yakoub-Agha, Ibrahim (Author) , Delforge, Michel (Author) , Cavo, Michele (Author) , Einsele, Hermann (Author) , Goldschmidt, Hartmut (Author) , Weisel, Katja (Author) , Rambaldi, Alessandro (Author) , Reece, Donna (Author) , Petrocca, Fabio (Author) , Massaro, Monica (Author) , Connarn, Jamie N. (Author) , Kaiser, Shari (Author) , Patel, Payal (Author) , Huang, Liping (Author) , Campbell, Timothy B. (Author) , Hege, Kristen (Author) , San-Miguel, Jesús (Author)
Format: Article (Journal)
Language:English
Published: March 10, 2021
In: The New England journal of medicine
Year: 2021, Volume: 384, Pages: 705-716
ISSN:1533-4406
DOI:10.1056/NEJMoa2024850
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa2024850
Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa2024850
Get full text
Author Notes:Nikhil C. Munshi, M.D., Larry D. Anderson, Jr., M.D., Ph.D., Nina Shah, M.D., Deepu Madduri, M.D., Jesús Berdeja, M.D., Sagar Lonial, M.D., Noopur Raje, M.D., Yi Lin, M.D., Ph.D., David Siegel, M.D., Ph.D., Albert Oriol, M.D., Philippe Moreau, M.D., Ibrahim Yakoub‑Agha, M.D., Ph.D., Michel Delforge, M.D., Michele Cavo, M.D., Hermann Einsele, M.D., Hartmut Goldschmidt, M.D., Katja Weisel, M.D., Alessandro Rambaldi, M.D., Donna Reece, M.D., Fabio Petrocca, M.D., Monica Massaro, M.P.H., Jamie N. Connarn, Ph.D., Shari Kaiser, Ph.D., Payal Patel, Ph.D., Liping Huang, Ph.D., Timothy B. Campbell, M.D., Ph.D., Kristen Hege, M.D., and Jesús San‑Miguel, M.D., Ph.D.
Description
Summary:Original Article from The New England Journal of Medicine — Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Item Description:Gesehen am 13.04.2021
Physical Description:Online Resource
ISSN:1533-4406
DOI:10.1056/NEJMoa2024850